MiNK Therapeutics director Dr. John Baldoni resigns effective Oct 31, 2023

MiNK Therapeutics, Inc.

Dr. John Baldoni resigns from board effective Oct 31, 2023, citing manufacturing advancements reducing need for his technical contributions.
He will serve as ad hoc technical advisor to the Company following his departure.
Baldoni did not step down due to any disagreement with MiNK's operations, policies, or practices.
Notice of resignation was sent on October 12, 2023; effective October 31, 2023.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Dr. John Baldoni

director

INKT · MiNK Therapeutics, Inc.

Effective: 2023-10-31
Filed: October 17, 2023, 7:59 PM ET

On October 12, 2023, Dr. John Baldoni sent notice of his resignation as a director at MiNK Therapeutics, Inc. (the "Company"), effective October 31, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. John Baldoni resigned as director at MiNK Therapeutics, Inc..

Action: resigned
Role: director

Exact text from the filing

On October 12, 2023, Dr. John Baldoni sent notice of his resignation as a director at MiNK Therapeutics, Inc. (the "Company"), effective October 31, 2023.

View on SEC.gov

MiNK Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-053752

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.